Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 60INDUSTRY 57NIH 7OTHER_GOV 3NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 1

Conditions

Sarcoma 2Rectal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Bone Neoplasms 1

Interventions

Radiotherapy 213Cisplatin 180Cyclophosphamide 168Doxorubicin 135Paclitaxel 125Vincristine 124Filgrastim 121Etoposide 103Carboplatin 100Methotrexate 83Gemcitabine 82Docetaxel 78Cytarabine 78Gene Expression Profiling 74Fluorouracil 74Prednisone 71Granulocyte Colony-Stimulating Factor 66Dexamethasone 66Leucovorin 62Polymerase Chain Reaction 47Immunohistochemistry 46Microarray Analysis 40Daunorubicin 38Irinotecan 37Ifosfamide 37Temozolomide 35Cetuximab 33Amplified Fragment Length Polymorphism Analysis 33Peripheral Blood Stem Cell Transplantation 32Mercaptopurine 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × NETWORK × olaparib × Clear all
NCT03838744 2024-12-04

TOMAS2

Italian Sarcoma Group

Phase 2 Completed
130 enrolled
Sarcoma

Sarcoma

NCT00535353 2023-08-04

AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Canadian Cancer Trials Group

Phase 1 Completed
26 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02398058 2021-04-14

TOMAS

Italian Sarcoma Group

Phase 1 Completed
50 enrolled
Sarcoma

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡